XRAY vs CHRW
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
XRAY
CHRW
Investment Advisor Scores
CHRW
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XRAY | CHRW | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.3291 | 21.5054 | XRAY |
| PEG Ratio | 0.633 | 1.8224 | XRAY |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.1% | 19.3% | CHRW |
| Earnings Growth | 15.2% | 23.8% | CHRW |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.2/100 | 70.0/100 | CHRW |
| Profit Margin | -15.0% | 3.7% | CHRW |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XRAY
NeutralMixed signals - no dominant trend phase, RSI 53
CHRW
DistributionPrice near a flattening SMA50 (slope -7.2%) with fading momentum, RSI 47
Fundamentals Snapshot
| Metric | XRAY | CHRW |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 6.1 | 18.8 |
| Trailing P/E | — | 26.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.2% |
| Gross Margin | 0.5% | 0.1% |
| Operating Margin | 0.1% | 0.1% |
| EPS | -2.73 | 5.24 |
| Dividend Yield | 0.04% | 0.02% |